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Three-dimensional (3D) synthetic hydrogels have recently emerged as desirable in vitro cell culture platforms 
capable of representing the extracellular geometry, elasticity, and water content of tissue in a tunable fashion. 
However, they are critically limited in their biological functionality. Hydrogels are typically decorated with a scant 
1-3 peptide moieties to direct cell behavior, which vastly underrepresents the proteins found in the extracellular 
matrix (ECM) of real tissues. Further, peptides chosen are ubiquitous in ECM, and are not derived from specific 
proteins. We developed an approach to incorporate the protein complexity of specific tissues into the design of 
biomaterials, and created a hydrogel with the elasticity of marrow, and 20 marrow-specific cell-instructive 
peptides. Compared to generic PEG hydrogels, our marrow-inspired hydrogel improves stem cell differentiation 
and proliferation. We propose this tissue-centric approach as the next generation of 3D hydrogel design for 
applications in tissue engineering. 
 
The vast majority of materials available to study how 
environmental cues direct cell fate are two-dimensional 
(2D), ranging from protein-coated surfaces to hydrogels1-3. 
However, 2D materials restrict cell adhesions to an x-y 
plane and force an apical-basal polarity4,5. To overcome 
this, researchers can better recapitulate the in vivo 
geometry of tissues using hydrogels to culture cells in 
three-dimensions (3D)6. Synthetic hydrogels made with 
polyethylene glycol (PEG) can be functionalized with 
peptide motifs that either elicit integrin-binding or allow for 
cell-mediated matrix degradation. Additionally, PEG 
hydrogels are extremely reproducible and are 
independently tunable in both stiffness and ligand density. 
Nevertheless, in some instances PEG-based hydrogels are 
generally considered inferior to more complex protein-
based hydrogels, like Matrigel, which may more accurately 
mimic native tissue. A main limitation in the use of naturally 
derived protein hydrogels is that the constituents are 
undefined and have extreme batch-to-batch variability. 
Thus, there is a need for synthetically engineered hydrogels 
designed to mimic structural and physiochemical features of 
specific in vivo environments. 
 
Bone marrow is the soft interior tissue between hard 
compact bone where many of our immune and stromal 
stem cells reside. Like every human tissues and organ, 
bone marrow has unique biophysical features that are 
critical for cell and organ function. For example, protein 
composition and tissue stiffness are important for cellular 
processes like migration and proliferation7,89, as well as 
regulating stem cell fate and organoid development10-12. 
Thus, it is not surprising that the surrounding extracellular 
matrix (ECM) plays a key role in the proper function of bone 
marrow because both hematopoietic and stromal progenitor 
cells originate from this tissue13. For example, both bone 
marrow stiffness and fibronectin are important for the 
maintenance of hematopoietic stem cell progenitors14. 
Additionally, marrow-derived stromal stem cells will 
differentiate into either bone or fat cells in response to 
mechanical cues15 and the presence or absence of 
vitronectin in 3D scaffolds can facilitate reversible 
differentiation into or from osteoblasts16. 
 
Despite clear evidence of the marrow ECM regulating the 
stem cell niche, in vitro stem cell culture platforms contain a 
mere fraction of the biochemical cues typical of the native 
tissue. Simple RGD-decorated polymers do not fully 
capture these cues, making it imperative to move toward 
environments that include the diversity of integrin-binding 
and protease-sensitive proteins in native tissues and 
organs. We propose a 3D ECM-focused material based on 
PEG and peptides. Unique to our approach is the 
development of a combination of bioinformatics and 
biomechanics to create a set of tissue-specific design 
criteria. This new class of tissue-centric PEG hydrogels 
captures the protein complexity of the native tissue in a 
material that is extremely tunable and can be fabricated 
with little technical expertise.  
  
A biomechanics and bioinformatics approach to create 
a synthetic human bone marrow 
  
A top-down engineering approach was used to identify the 
physical and chemical properties of bone marrow that could 
be represented by a synthetic PEG hydrogel (Figure 1a-b). 
Bone marrow elasticity was measured via shear rheology, 
indentation, and cavitation rheology7. We then 
approximated this elasticity synthetically by adjusting the 
polymer-polymer distance of the hydrogel, a material that is 
inherently hydrophilic and mimics marrow’s high water 
content. We have previously demonstrated that bone 
marrow is a benign elastic material7. Because the 
viscoelastic properties contribute to stem cell fate17, we 
compared the compressive properties of both porcine 
marrow and of a PEG hydrogel. Both materials closely 
followed a Hertzian model (Suppl. Figure 1 a-b), suggesting 
that under these conditions, PEG is an appropriate physical 
model for the elasticity of marrow.  
 
The ECM proteins of marrow were identified using histology 
and mass spectrometry (Figure 1a). ECM proteins were 
represented by specific peptide sequences that are either 
responsible for high affinity binding to transmembrane 
integrin proteins 18 or are highly susceptible to cleavage by 
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matrix metalloproteinases (MMPs) (Suppl. Table 1 and 2). 
Integrins are the largest class of cell adhesion receptors 
that mediate attachment to the ECM and activate 
intracellular signaling19. Collectively the MMP family can 
degrade all components of the ECM and is important for 
tissue homeostasis20. Integrin-binding proteins and MMP 
protein substrates were identified in human bone marrow 
using the histology data available in the Protein Atlas 
(Suppl. Table 3)8. Peptide motifs that elicit integrin binding 
were identified for each protein and displayed as mono-
functional moieties in the hydrogel (Figure 1b-c, Suppl. 
Table 5-6)21-29. Conversely, di-functional peptides that 
selectively degrade in the presence of cell secreted MMPs 
were associated with the protein substrates found in 
marrow (Figure 1b,d, Suppl. Table 6). The histological 
scores for each protein were used to determine the 
quantitative peptide amounts to be included in the final 
bone marrow hydrogel (Figure 1c-d). Representative 
images from the tissue histology in the Protein Atlas are 
displayed in Figure 1c and d. ECM proteins in human bone 
marrow30 were analyzed via liquid chromatography-mass 
spectrometry (LC-MS, Suppl. Figure 1c) and compared to 
control tissues (lung and brain, Suppl. Table 4) to confirm 
that our histology-driven approach identified the unique 
ECM signature of marrow. The LC-MS data from human 
bone marrow was most similar to the bone marrow peptide 
cocktail (Suppl. Figure 1d), and protein substrates from 
bone marrow ECM could be cleaved by active MMP 
enzymes (Suppl. Figure 1e). Together, these data indicated 
our technique could accurately filter for the unique integrin-
binding and MMP-degradable protein signature of marrow.  
  
Functional validation of peptide domains 
  
Figure 1. Adapting a PEG hydrogel to mimic the physical and chemical properties of bone marrow tissue. a) Tissues have specific 
defining physical and chemical properties such as water content, elasticity, integrin-binding, and MMP-degradable proteins. These properties 
can be quantified in real bone marrow tissue using rheology, mass spectrometry, and tissue histology (body image from Protein atlas). These 
features are represented synthetically by tuning the hydrogel crosslinking and incorporating biofunctional peptides. c) Here, bone marrow tissue 
(top left, image from Jansen et al., 2015) is mimicked in a hydrogel (bottom left) composed of an 8-arm PEG macromer functionalized with c) 
13 mono-functional integrin-binding peptides, and crosslinked with d) 7 di-functional MMP-degradable peptides and a linear PEG-dithiol. The 
known functional sequence for each peptide is depicted in blue with the percentage it is present in the hydrogel (% relative to other peptides). 
All histology images are representative of each protein in human bone marrow tissue (images from the Protein Atlas). The lines in d) connect 
each MMP to their known protein substrates and the slash (/) indicates the cleavage location for each enzyme on the matched peptide. 
 
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/275842doi: bioRxiv preprint first posted online Mar. 3, 2018; 
Human mesenchymal stem cells (MSCs) were used to test 
whether stromal cells, which are highly abundant in the 
marrow, could recognize and respond appropriately to the 
peptides in our bone marrow cocktail. We developed a 
competitive cell adhesion assay to measure binding to 
integrin peptides, which took advantage of the decrease in 
cell area observed during cell adhesion (Suppl. Video 1 and 
2). We covalently attached the full integrin-binding peptide 
cocktail (Figure 1c) to a glass coverslip upon which MSCs 
were seeded in the presence or absence of individual 
peptides from that same cocktail solubilized in the cell 
medium (Figure 2a). We validated that cell adhesion to the 
surface was driven by the attached peptides, not serum 
(Suppl. Figure 2a), and that protein did not passively bind to 
peptide-coated coverslips in the experimental time frame 
(Suppl. Figure 2b). We observed a decrease in the area of 
cells pre-treated with peptides, so adhesion was quantified 
using cell area measurements at two hours (Figure 2a). 
 
All tested cells had decreased adhesivity when dosed with 
the bone marrow integrin-binding peptide cocktail (Figure 
2b, Suppl. Figure 2d). Across three MSC sources from 
human donors and one immortalized cell line, most 
individual peptides decreased MSC spreading at the 
concentration at which they were present in the cocktail 
(Figure 2b). The Collagen I and Tenascin C peptides did 
not significantly alter MSC adhesion in any case, but 
promoted an anti-adhesive phenotype in a human breast 
cancer cell line (Suppl. Figure 2d). Interestingly, the 
immortalized MSC cell line was more responsive to 
individual peptide treatments compared to the donor cells 
(i.e. more peptides decreased adhesion). Since ECM 
proteins can facilitate both adhesion to and dissociation 
from the matrix, and we see those phenotypes in this data, 
we conclude that each peptide in the mimic can direct cell 
adhesion to and from our hydrogel matrix. 
  
Crosslinker degradation was validated using a cell invasion 
assay. Cytodex beads were coated with MSCs and 
encapsulated for 6 days into the hydrogels crosslinked with 
a single MMP degradable peptide or the full set of 
degradable crosslinks at the same molar ratio of thiol to 
maleimide (Figure 2c). When degradable peptides were 
present, MSCs were able to branch further into the 
surrounding network (Figure 2d-e). MSCs branched the 
furthest in the bone marrow-cocktail, MMP-3, and -14 
crosslinked hydrogels, suggesting that certain individual 
peptides can be extremely susceptible to degradation and 
peptide combinations can improve material degradation by 
bone marrow cells. Since all the MMP peptides have been 
optimized to selectively degrade in response to their 
respective enzyme22, we suggest that MMP expression 
would likely explain the differential degradation observed. In 
sum, we observed degradation for all MMP peptide 
crosslinkers and found that the full bone marrow-inspired 
degradable peptide cocktail was optimal for MSC 
branching. 
  
Optimal conditions for coupling marrow-specific 
peptides 
  
This is the first time 20 unique peptide motifs have been 
incorporated into a PEG hydrogel. Prior to this work, the 
most complex bioactive PEG hydrogel contained 3 unique 
peptides31,32. Thus, it was important to identify the ideal 
conditions to incorporate these peptides into the network. 
Our peptides are coupled using a Michael-type addition 
reaction, with a maleimide as the Michael-type acceptor. 
The maleimide-thiol reaction is biocompatible and has been 
c
d
e1hT 2 3Donor
-1 10
Log10 Fold Change from NT
a b
No Treatment
Bone Marrow
RGD
Netrin 1
Fibronectin
Collagen I, IX
Fibrinogen α
Osteopontin
Thrombospondin
Fibrinogen γ
Laminin α
Collagen I
Tenascin C
Laminin β
Laminin  γ
0 50 100 150
0
2000
4000
6000
Time (min)
C
el
l A
re
a 
(μ
m
2 )
Control Treated
*** **
**
**
**
**
**** ****
****
*
**
**
*
* * *
**
**** ***** *
Scale 100μm
Scale 200μm
Scale 100μm
MMP 1Non-degradable (N)
MMP 2 MMP 3
MMP 7 MMP 9
MMP 14
Bone Marrow (BM)
MMP 13
Encapsulate cell-coated beads into MMP-
degradable peptide crosslinked hydrogels 
Day 1
Day 6
Seed  peptide-treated cells onto 
peptide-coated coverslips 
2D Integrin-binding peptide validation 3D MMP-degradable peptide validation
Bead
Branch length
N 1 2 3 7 9 13 14 BM
0
200
400
600
M
ax
 B
ra
nc
h 
Le
ng
th
/B
ea
d 
(μ
m
)
**
***
****
Figure 2. Peptide moieties can be bound and degraded by MSCS. a) Cells were treated with peptides and seeded onto coverslips coated with 
the bone marrow peptide cocktail. MSC area was measured over time for cells not treated (control, black) or pre-treated for 30 minutes prior 
(blue) with soluble integrin binding peptides and allowed to adhere to a surface coupled with the bone marrow peptide cocktail. Representative 
cell images (scale 50 μm) and outlines of MSCs 2 hours after seeding (bottom). Error bars represent SEM. b) Heat map depicting the log10 fold 
change in cell area at 2 hours compared to no treatment (NT) for each integrin-binding peptide moiety in the mimic across one cell line, hTERT 
MSCs (hT), and three donor MSCs (1-3) (BM=bone marrow peptide cocktail) (N≥2, n≥20 per cell). c) Representative image of MSCs seeded on 
cytodex beads (black outline) and encapsulated into a hydrogel with one MMP degradable crosslinker (Cell area=red, branch length=green). d) A 
box and whisker plot for the maximum branch length per bead in each hydrogel condition. e) Representative cell and bead traces in each 
hydrogel condition, where the lighter colored circle is the bead and the darker color is the cell trace (N=2, n≥15 per cell). Significance is 
determined using a two-tailed t-test where p=0.05. 
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shown to provide the most efficient incorporation of ligands 
and the largest range of bulk properties compared to similar 
PEG hydrogels33. A thiol quantification assay was used to 
identify uncoupled peptides in solution because the 
Michael-type donor for this reaction is a thiol (Suppl. Figure 
3a). A number of parameters regulated the efficiency of 
peptide incorporation, including polymer wt% and the molar 
percentage of reactive pairs (Suppl. Figure 3b-e). However, 
these properties also change the effective Young’s modulus 
of the hydrogel. Overall, we found that an 8-arm PEG 
enabled increased crosslinking without reducing reaction 
efficiency (Suppl. Figure 3d). 
  
We achieved  >98% coupling of mono-functional integrin-
binding peptides and >97% of di-functional MMP 
degradable peptides using an 8-arm PEG at 20 wt% (Figure 
3a-b). Optimal reaction conditions for integrin-binding 
peptides occurred in PBS at pH 7.4, but we did note that 
the peptide cocktail was less soluble in this buffer than in 
DMSO (Suppl. Figure 3f-g). Separately, we reduced a 
hydrogel using sodium borohydride to ensure that disulfide 
bonds between the thiols were not preventing the Michael-
addition reaction. This reduction did not significantly 
increase the number of free thiols found, indicating that 
>95% of the material bonds are from the Michael-type 
addition reaction (Suppl. Figure 3h).   
  
Matrix assisted laser deposition ionization time of flight was 
used to identify the peptides that did not couple to the 
matrix. First, we made a solution of all the peptides, without 
PEG present, and identified all except DGEA and 
AEIDGIEL (Figure 3e-f, Suppl. Figure 4a-b). These are both 
highly negatively charged peptides, which do not ionize 
easily. To confirm this, AEIDGIEL could not be identified 
even at a high concentration if non-charged peptides were 
present (Suppl. Figure 4c-f). We then formed hydrogels with 
all the peptides, and attempted to find unreacted peptides in 
solution. Only two peptides were identified in the 
supernatant but at a significantly reduced intensity (Figure 
3g-h). Taken together, this data shows that our peptides are 
crosslinked into the hydrogel close to the expected 
concentration. 
  
PEG hydrogels mimic the bulk mechanics of bone 
marrow 
  
The mechanical properties of engineered materials can 
influence the migration and differentiation of marrow-
derived stromal and hematopoietic stem cells14,15,17,34-37. We 
have previously shown that porcine bone marrow has an 
average modulus of 4.4±1.0 kPa at physiological 
temperature (Figure 4a)7, and recent work has shown that 
hematopoietic progenitor populations can be maintained in 
the presence of fibronectin at this modulus14. These studies 
highlight an important role for the mechanical properties of 
bone marrow tissue to direct stem cell fate and function. A 
PEG hydrogel crosslinked with a linear dithiol can be 
adapted to span the range of stiffness observed in bone 
marrow (Suppl. Figure 3c). While a number of properties 
contribute to stiffness and can be used to tune modulus, a 
20 wt%, 8-arm, 20K PEG hydrogel best matched the 
modulus of porcine bone marrow tissue (Figure 4b).  
  
A benefit of PEG hydrogels is the mechanical and chemical 
properties can be independently tuned. To ensure our 
chemical modifications did not change the stiffness of the 
material, we individually incorporated them into the 
hydrogel and tested each of their effects on stiffness. 
Incorporation of the MMP-sensitive crosslinkers in lieu of 
PEG-dithiol did not alter the hydrogel modulus (Figure 4b), 
and mono-functional integrin-binding peptides could be 
incorporated up to a 4 mM total concentration without 
compromising the bulk modulus (Figure 4c). Through 
separate cell tracing experiments, we found that a 2 mM 
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Figure 3. Bone marrow peptides couple to the hydrogel at the expected concentration. a) The percentage of unreacted thiols when mono-
functional peptides are added to a solution of PEG dissolved in PBS at pH 7.4. b) The percentage of unreacted thiols 10 minutes post-crosslinking 
an 8-arm PEG hydrogel at a 1:1 molar ratio of thiol to maleimide. Error bars represent the SEM (N≥1, n≥3). MALDI-TOF spectrum (top) and 
identified peptide peaks (bottom) for the c) and d) bone marrow mono-functional peptide cocktail, e) and f) the bone marrow di-functional peptide 
crosslinkers, and g) and h) the supernatant of a bone marrow hydrogel swelled for 4 hours in PBS. 
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concentration of integrin-binding peptides was needed to 
achieve significant MSC spreading at 24 hours. We 
therefore used 2 mM of total integrin-binding peptides in a 
20 wt%, 8-arm, 20K PEG crosslinked with our MMP-
degradable cocktail as the final bone marrow formulation 
(Figure 4d-e).  
  
The synthetic bone marrow hydrogel provides a niche 
for MSC growth and differentiation  
 
Our results demonstrate an approach to identify the matrix 
stiffness, integrin-binding peptides, and MMP-degradable 
sites in real bone marrow. This information was used to 
create a PEG hydrogel with tissue-inspired properties. As a 
comparison to the current standard for in vitro synthetic 3D 
culture systems, we compared this bone marrow hydrogel 
to the commonly used RGD-functionalized PEG hydrogel 
and tissue culture polystyrene (TCPS). We explored both 
cell growth and differentiation because these are two 
phenotypes exhibited by MSCs in real bone. After one week 
in culture, the same percentage of MSCs expressed Ki67 
and p21 on TCPS as in the bone marrow gel, where cells in 
the RGD-functionalized PEG hydrogel were less 
proliferative and had increased cellular senescence (Figure 
5a-c). 
 
We next explored whether MSCs were differentiating. 
Interestingly, α-smooth muscle actin was highest in the 
bone marrow hydrogel, suggesting reduced clonogenicity 
and fat differentiation (Figure 5d)38,39. All donor MSCs were 
capable of differentiating into bone and fat, shown by 
staining hydroxyapatite or lipids, respectively (Suppl. Figure 
5). Differentiation capacity was measured by quantifying the 
ability of cells to differentiate in the presence or absence of 
differentiation medium. In the bone marrow hydrogel, MSCs 
had a higher capacity to differentiate into bone compared to 
RGD-functionalized hydrogels (Figure 5e). In both the 
RGD-functionalized and bone marrow hydrogels, 
spontaneous hydroxyapatite formation was observed 
without the presence of differentiation cues (Suppl. Figure 
6). Adipose differentiation was similar in both materials 
(Figure 5f). Our results correlate with reports that α-smooth 
muscle actin positive MSCs filtered from bone marrow have 
a higher osteogenic differentiation potential39. Interestingly, 
this study also found that these cells had a higher in vivo 
tissue regeneration capacity. 
 
This led us to hypothesize that the bone marrow hydrogel 
provided a niche for MSCs to differentiate and respond to 
growth factors typically present in the bone milieu that are 
responsible for MSC activation, differentiation, proliferation, 
and trafficking40,41. We treated MSCs encapsulated in 
hydrogels with a panel of proteins associated with either 
MSC differentiation or proliferation42. We observed that 
MSCs encapsulated in the bone marrow hydrogel were 
more metabolically active when exposed to this panel than 
when encapsulated in the RGD-functionalized hydrogel 
(Figure 5g). This supports the notion that specific integrin 
binding in the marrow influences soluble factor signaling. 
  
The described 3D bone marrow hydrogel is highly tunable 
and can be readily used to probe the underlying 
mechanisms driving cellular differentiation and phenotypes 
caused by soluble cues. In vivo the bone marrow niche 
needs to be able to support progenitor populations and to 
direct cell differentiation, a feature we demonstrate here. 
Overall, we only observed this unique biological response 
by combining both the physical and chemical properties of 
real bone marrow into a PEG hydrogel. While we have 
focused specifically on bone marrow, this approach could 
be applied to any tissue in the human body, and represents 
the next generation of tissue-driven hydrogel design for cell 
culture. 
 
Outlook 
 
Here, we combined proteomic-based bioinformatics and 
biomechanics to make a bone marrow-customized PEG 
hydrogel. This marrow-mimicking hydrogel is composed 
simply of PEG and peptides, which polymerizes in 10 
seconds under physiological conditions. The novelty of our 
hydrogel is that it includes 20 unique peptide moieties to 
more fully capture the integrin-binding and MMP sensitive 
domains of ECM proteins typical of marrow. Competitor 
hydrogels typically incorporate 1-3 of these types of 
peptides and approximate native tissue by incorporating 
tissue-specific cells.  Another approach is to implant bone-
like scaffolds into mice to recruit cells and then use ex vivo 
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Figure 4. The PEG hydrogel accurately models the bulk compressive properties of bone marrow tissue. a) Rheology data from Jansen et 
al., 2015 for the effective Young’s modulus (EEff) of porcine bone marrow at 35°C. b) The EEff for 20 wt%, 8-arm, 20K PEG hydrogels crosslinked 
at a 1:1 thiol to maleimide molar ratio with 1.5K PEG-dithiol (PDT, black) or with the bone marrow cocktail of 1.5K PDT and MMP crosslinkers 
(MMP, green). c) The EEff for 20 wt%, 8-arm, 20K PEG hydrogels crosslinked at a 1:1 thiol to maleimide molar ratio with PDT and coupled with 
different concentrations of the bone marrow peptide cocktail for 10 minutes before gelation. d) MSCs circularity with respect to peptide 
concentration and e) representative cell traces for cells encapsulated in a 20 wt%, 8-arm, 20K PEG-crosslinked with the bone marrow cocktail. 
The significance is determined using a two-tailed t-test where p=0.05, and error bars represent the SEM. (N≥2, n≥3 for mechanical testing; N≥2, 
n≥10 for cell circularity). 
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culturing to maintain bone marrow cell populations in 
culture long-term43-45. This latter approach is labor intensive 
and requires technical expertise to fabricate, limiting its 
throughput. We also argue that these models under-
represent the chemical diversity of native tissue because, 
while they capture the hierarchical structure of bone, they 
neglect the unique protein properties present in bone 
marrow.  
 
Decellularized matrix is currently the only in vitro material 
capable of including the protein complexity of real 
tissue46,47. It is time consuming to make and not batch-
controlled, leading to inconsistent results and an inability to 
separate ensuing variability between the cells and the 
starting material. Tissue-specific cells can also be made to 
secrete their own matrix for cell culture use, but this matrix 
is not necessarily representative of the native 
environment48. As an alternative, we demonstrate an 
approach to synthetically represent the tissue-specific 
properties of bone marrow, while maintaining control and 
simplicity. One appeal of this system is that it could be used 
to co-culture cells or be formed around any cell or organoid 
of interest11. Additionally, because features can easily be 
tuned, pseudo ECM knock-out environments can be used 
to understand ECM-mediated cell signaling. Future work 
should focus on a more thorough understanding of how 
each component of the ECM, and how perturbations of 
these properties, contributes to and changes observed cell 
phenotypes.  In sum, we have captured the ECM of real 
bone marrow using simple chemistry in a widely-used 
material that is adaptable to high throughput, systems-level 
screens49. We propose this approach could be applied to 
any tissue or organ, creating a new class of designer 
biomaterials that can be employed to elucidate ECM-driven 
mechanisms in cells not easily achieved by other systems. 
  
Materials and methods 
  
Cell culture 
All cell culture supplies were purchased from Thermo 
Fisher Scientific (Waltham, MA) unless otherwise noted. 
Human mesenchymal stem cells (MSCs) were received 
through a material transfer agreement with Texas A&M 
University College of Medicine Institute for Regenerative 
Medicine at the Scott & White Hospital funded by the 
National Institute of Health (NIH). MSCs from three donors 
were cultured in alpha minimum essential medium (αMEM), 
supplemented with 16.5% fetal bovine serum (FBS) and 1% 
L-glutamine, and used between the 2nd and 6th passage. 
The hTERT MSCs were provided from Dr. Junya Toguchida 
and the human breast cancer cell line MDA-MB-231 was 
provided by Dr. Shannon Hughes. These were cultured in 
Dulbecco’s modified eagle’s medium (DMEM), 
supplemented with 1% L-glutamine, 1% penicillin–
streptomycin, 10% FBS, 1% non-essential amino acids, and 
1% sodium pyruvate. 
  
Identifying integrin-binding and MMP-degradable proteins in 
bone marrow 
Manual data mining was used to identify 48 integrin-binding 
proteins and 44 MMP-degradable proteins (Suppl. Table 1 
and 2). These proteins were quantified in human bone 
marrow using the Protein Atlas (Suppl. Table 3)8. The 
histological score was annotated for each protein. The 
value of the histological score for the hematopoietic cells 
was averaged across all the patients scored. This list was 
used to identify which proteins or protein substrates would 
be represented by integrin-binding moieties or degradable 
peptide sequences for the majority of the proteins identified 
in bone marrow tissue. The histological value was used to 
determine the percentage of each integrin-binding peptide 
and MMP-degradable crosslinker to use for proteins in bone 
marrow. 
  
Solid-phase peptide synthesis 
All peptides were synthesized on a CEM’s Liberty Blue 
automated solid phase peptide synthesizer (CEM, 
Mathews, NC) using Fmoc protected amino acids (Iris 
Biotech GMBH, Germany). Peptide was cleaved from the 
resin by sparging-nitrogen gas through a solution of 
peptide-resin and trifluoroacetic acid (TFA), 
triisopropylsilane, water, and 2,2′-
(Ethylenedioxy)diethanethiol at a ratio of 92.5:2.5:2.5:2.5 % 
by volume, respectively (Sigma-Aldrich, St. Louis, MO) for 3 
hours at room temperature in a peptide synthesis vessel 
(ChemGlass, Vineland, NJ). The peptide solution was 
filtered to remove the resin and the peptide was precipitated 
out using diethyl ether at -80°C (Thermo). Molecular mass 
was validated using a MicroFlex MALDI-TOF (Bruker, 
Billerica, MA) using α-cyano-4-hydroxycinnamic acid as the 
matrix (Sigma-Aldrich). Peptides were purified to ≥95% on a 
VYDAC reversed-phase c18 column attached to a Waters 
2487 dual λ adsorbable detector and 1525 binary HPLC 
pump (Waters, Milford, MA). 
  
The following sequences were synthesized: GCGDGEA, 
GPRGGC, CSRARKQAASIKVAVADR, CSVTCG, 
CGGYSMKKTTMKIIPFNRLTIG, GCKQLREQ, 
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Figure 5. The bone marrow hydrogel maintains MSC stemness. 
Staining for a) Ki67, b) p21, c) beta-galactosidase, and d) α-smooth 
muscle actin positive cells in a hydrogel with no degradability and 2 
mM RGD (RGD) or the bone marrow hydrogel (BM). e) Oil Red O or 
f) Osteoimage differentiation capacity normalized to the RGD 
hydrogel. g) Log10 of cell metabolic activity three days after cell 
encapsulation into the bone marrow hydrogel or an RGD hydrogel for 
all donor MSCs. Each growth factor was dosed at 20 ng/mL in cell 
culture medium. h) Schematic to compare how the two hydrogels 
impact observed MSC phenotypes. 
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GCDPGYIGSR, GRGDSPCG, GCRDRPFSMIMGDRCG, 
GCRDGPLGLWARDRCG, GCRDVPLSLTMGDRCG, 
GCRDGPQGIWGQDRCG. 
  
The following sequences were purchased from GenScript 
(China) at >96% purity: CGGSVVYGLR, 
CGPHSRNGGGGGGRGDS, CGP(GPP)5GFOGER(GPP)5, 
CGGAEIDGIEL, GCRDIPESLRAGDRCG, 
GCGGQWRDTWARRLRKFQQREKKGKCRKA, 
GCRDVPLSLYSGDRCG, GCRDSGESPAYYTADRCG, 
GCRDVPMSMRGGDRCG 
  
Polymerization of 3D bone marrow hydrogels 
A 20K 8-arm PEG-maleimide (Jenkem Technology, Plano, 
TX) was reacted with 2mM of the bone marrow integrin-
binding peptide cocktail (Suppl. Table 4) for 10 minutes in 
serum free medium at pH 7.4. This solution was crosslinked 
at a 1:1 molar ratio of thiol to maleimide in PBS at pH 7.4, 
and the crosslinker cocktail was composed of 75 molar% of 
1.5K linear PEG-dithiol (Jenkem) and 25 molar% of the 
MMP-degradable cocktail (Suppl. Table 5). Gels were 
polymerized in 10 μL volumes with 1,000 cells/μL and cell 
culture medium was added after 5 minutes to swell the 
material for at least 18 hours before use. Other hydrogel 
combinations were made with a 2K, 10K, and 20K 4-arm 
PEG-maleimide, all crosslinked at a 1:1 molar ratio of thiol 
to maleimide with 1.5K linear PEG-dithiol. 
  
ECM protein enrichment from tissues 
Tissue samples from healthy women between ages 45-60 
were obtained from Cooperative Human Tissue Network 
funded by the National Cancer Institute (NCI) under IRB 
exempt status. Insoluble ECM proteins were extracted from 
500 mg of tissue using the CNMCS compartmental protein 
extraction kit according to the manufacturer’s instructions 
(Millipore, Billerica, MA). This resulted in an insoluble ECM 
pellet. 
  
Mass spectrometry 
Two biological replicates were analyzed for human bone 
marrow, brain, and lung tissues. The ECM-rich pellet 
remaining from the CNCMS kit was solubilized and reduced 
in 8 M urea, 100 mM of ammonium bicarbonate, and 10 
mM dithiothreitol (DTT) (Thermo) for 30 minutes at pH 8 
and 37°C. Samples were alkylated with 25 mM 
iodoacetamide (Sigma-Aldrich) in the dark at room 
temperature for 30 minutes before the solution was 
quenched with 5 mM DTT. Prior to cleavage, the solution 
was diluted to 2 M urea with 100 mM ammonium 
bicarbonate at pH 8. Proteins were cleaved via trypsin 
(Thermo) and Lys-C endoproteinase (Promega, Madison, 
WI), at a ratio of 1:50 enzyme to protein overnight (12-16 
hours) at 37°C. Samples were cleaned and concentrated 
using a C18 column (Thermo). A reverse phase LC gradient 
was used to separate peptides prior to mass analysis. Mass 
spectrometry analysis was performed in an Orbitrap Fusion 
Tribrid (Thermo). Peptides were aligned against the 
Matrisome using the Thermo Proteome Discoverer 
1.41.1418. Parameters used trypsin as a protease, with 4 
missed cleavage per peptide, a precursor mass tolerance of 
10 ppm, and fragment tolerance of 0.6 Da. 
  
MMP degradation of bone marrow tissue 
The MMP degradation assay was adapted from a protocol 
by Skjøt-Arkil et al. [6]. The ECM-rich pellet from the 
CNMCS kit was solubilized in 8 M urea at pH 8 and 
lyophilized in 200 μg aliquots. The lyophilized ECM was 
resuspended in 100 mM Tris-HCl, 100 mM NaCl, 10 mM 
CaCl2, and 2 mM ZnOAc at pH 8.0. (Sigma-Aldrich) MMP 1, 
MMP-3 (901-MP, 513-MP, R&D Systems, Minneapolis, MN) 
MMP 2, MMP 9, MMP 13, MMP 14 (ab125181, ab168863, 
ab134452, ab168081, Abcam, Cambridge, MA), and MMP 
7 (CC1059, Millipore) were activated according to the 
manufacturer’s instructions and mixed individually with 200 
μg of tissue per 1 μg of either active enzyme, or MMP 
buffer was used as a control. Samples were mixed for 18 
hours at 37°C, at which point the reaction was terminated 
with 25 μM of GM6001 (Millipore). Digested protein was run 
on a Novex 12% Tris-glycine polyacrylamide gel, stained 
using silver stain (Thermo) and imaged using the IN Genius 
Syngene Bioimaging platform (Frederick, MD). 
  
Competitive binding assay 
Glass coverslips were prepared with 1 ug/cm2 of the bone 
marrow peptide coupled to the surface using amine 
chemistry described by Barney et al2. Cells were seeded at 
4,000 cells/cm2 in their normal growth medium after 30 
minutes of pretreatment with individual peptides or the 
complete bone marrow cocktail. Bone marrow was dosed at 
a molar amount of 25 nmol/mL of medium and the molar 
amount dosed for each individual peptide was as follows: 
GRGDSPCG at 600 pmol/mL, CGPHSRNGGGGGGRGDS 
and GCGGQWRDTWARRLRKFQQREKKGKCRKA at 220 
pmol/mL, CGP(GPP)5GFOGER(GPP)5, CGGSVVYGLR, 
and GPRGGC at 160 pmol/mL, CSVTCG and 
CGGYSMKKTTMKIIPFNRLTIG at 100 pmol/mL, 
GCGDGEA, CSRARKQAASIKVAVADR, GCKQLREQ, and 
CGGAEIDGIEL at 60 pmol/mL, and GCDPGYIGSR at 40 
pmol/mL. Cells were imaged beginning 10 minutes after 
seeding in an environment controlled Zeiss Axio Observer 
Z1 microscope (Carl Zeiss, Oberkochen, Germany) using 
an AxioCam MRm camera and an EC Plan-Neofluar 20X 
0.4 NA air objective. Images were taken using Zeiss Axio   
Observer Z1 (Carl Zeiss) at five-minute intervals for 2 hours 
and cell areas were traced in ImageJ (NIH, Bethesda, MD). 
  
Outgrowth of cells into MMP sensitive hydrogels 
Cytodex1 microcarrier beads (Sigma-Aldrich) were swollen 
in sterile 1X PBS (1 g beads/50 mL PBS) and autoclaved 
for 30 minutes at 121°C. Flasks were coated with poly (2-
hydroxyethy methacrylate) suspended in ethanol at 20 
mg/mL and allowed to evaporate in a biosafety cabinet for 
30 minutes to make them non-adherent. Cells were seeded 
at 10-50 cells/bead in non-adherent flasks at a 0.1 mL of 
beads/mL of media. The flask was shaken every hour for 4 
hours to ensure coating onto beads, and cells were allowed 
to grow on beads for 48 hours post-seeding. Hydrogels 
were prepared with 4-arm PEG-maleimide at a 20wt% 
cross-linked at a 1:1 molar ratio with 50% 1.5K linear PEG-
dithiol and 50% of each individual MMP degradable peptide 
sequence (Suppl. Table 5). Hydrogels were imaged at days 
1, 3, and 6 and all image analysis was performed in ImageJ 
(NIH). 
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Validation of peptide incorporation 
The Measure-iT thiol kit was used to quantify unreacted 
thiols (Thermo). Buffers were prepared according to the 
manufacturer’s guidelines. Mono-functional peptides were 
incorporated at 1 mM in a 100 μL volume of PEG-
maleimide for 10 minutes before reacting with 100 μL of the 
Measure-iT thiol working solution. Di-functional peptides 
were reacted with PEG-maleimide in 10 μL volumes for 10 
minutes before reacting with 100 μL of the Measure-iT thiol 
working solution. The hydrogel was reduced by immersing 
hydrogels in sodium borohydride (NaBH, Sigma-Aldrich) in 
water at a molar ratio of 4:1 NaBH to thiol for 4 hours before 
adding Measure-iT thiol working solution. All solutions or 
hydrogel supernatants were read at an excitation of 494 nm 
and emission of 517 nm within 5 minutes of the reaction. To 
quantify which peptides did not react, the supernatant from 
a hydrogel swollen in water for 2 hours was lyophilized, 
resuspended in 1:1 acetonitrile and ultrapure water with 
0.1% TFA at a theoretical concentration 100 pmol/μL, 
assuming 0% of the peptides coupled to the hydrogel. 
Peptides were identified using a MicroFlex MALDI-TOF 
(Buker) with either saturated α-cyano-4-hydroxy cinnamic 
acid or 10 mg/mL 2,5-dihydroxybenzoic acid as our matrix 
(Sigma-Aldrich). 
  
Hydrogel mechanical and structural characterization 
The effective Young’s modulus was measured using 
indentation testing on 10 μL volumes of the 3D hydrogels. A 
custom-built instrument was used as previously 
described50.  Bone marrow mechanical data was taken from 
Jansen et al7. For this application, a flat punch probe was 
applied to samples at a fixed displacement rate of 10 μm/s, 
for maximum displacement of 100 μm. The first 10% of the 
linear region of the force-indentation curves were analyzed 
using a Hertzian model modified by Hutchens et al. to 
account for dimensional confinement described by the ratio 
between the contact radius (a) and the sample height (h) 
(0.5<a/h<2)51. 
  
MSC spreading with varying peptide concentrations 
hTERT MSCs were encapsulated into the 3D bone marrow 
hydrogels (described above) with peptide concentrations 
varying from 0 to 4 mM of the bone marrow peptide 
cocktail. After 24 hours, hydrogels were fixed in 10% 
formalin for 10 minutes and stained with AlexaFluor 555 
phalloidin (A34055, ThermoFisher, 1:40) and DAPI 
(ThermoFisher, 1:10,000). Cells were imaged Zeiss 
Spinning Disc Observer Z1 microscope (Carl Zeiss) using 
an HRm AxioCam and an EC Plan-Neofluar 20X 0.5 NA air 
objective. Images were taken using Zen (Carl Zeiss) and 
cell areas were traced in ImageJ (NIH). 
  
Differentiation of MSCs across biomaterials 
Differentiation of cells was assayed across 5 different 
biomaterial platforms: tissue culture polystyrene, glass 
coverslips, 2D PEG hydrogels, and 3D PEG hydrogels with 
either the bone marrow cocktail or the RGD peptide 
functionality. Glass coverslips were prepared the same way 
as for the competitive binding assay. 2D PEG-
phosphorylcholine (PEG-PC, Sigma-Aldrich) hydrogels 
were prepared with bone marrow peptides coupled to the 
surface at 1 ug/cm2 as described by Herrick et al3. PC was 
kept at 17 wt% (0.6 M) and PEG is added at 1.1 wt% (0.015 
M) for a ~4 kPa hydrogel. Cells were seeded at a density of 
15,000 cells/cm2 on plastic and coverslips, 30,000 cells/cm2 
for 2D hydrogels, and at a density of 2,000 cells/μL in 3D 
platforms. For osteoblast differentiation, cells were provided 
cell culture medium supplemented with 10 mM glycerol 
phosphate (Santa Cruz Biotechnology, Dallas, TX), 1 nM 
dexamethasone, and 50 M L-ascorbic acid 2-phosphate 
(Sigma-Aldrich). For adipose cell differentiation, cells were 
provided cell culture medium supplemented with 0.5 μM 
isobutylmethylxanthine, 0.5 M dexamethasone, and 50 M 
indomethacin (Sigma-Aldrich). Cells were maintained for 21 
days with medium changes every 3-4 days. After 21 days, 
cells and materials were fixed in 10% formalin (Thermo) 
prior to staining. Oil Red O (Thermo) staining was used to 
identify lipid formation and hydroxyapatite formation was 
identified using an Osteoimage mineralization assay 
(Lonza, Basel, Switzerland). Both staining procedures were 
performed according to the manufacturer’s instructions. 
Differentiation capacity was determined by dividing the 
percentage of cells that differentiated in differentiation 
medium by the percentage that differentiated in stem cell 
medium. This number for both conditions was normalized to 
the RGD hydrogel. 
  
Cell proliferation in response to growth factors 
MSCs were seeded at 1,000 cells/μL in the bone marrow 
hydrogel or a 20wt%, 20K PEG-maleimide functionalized 
with 1 mM GRGDSPC (Genscript) crosslinked 100% with 
1.5K PEG-dithiol. Gels were individually dosed with 20 
ng/mL of select growth factors: transforming growth factor-
β1 (Millipore), transforming growth factor-β2 (Sigma-Aldrich), 
transforming growth factor-α, insulin-like growth factor, 
fibroblast growth factor-1, epidermal growth factor (R&D 
Systems), vascular endothelial growth factor-A, and 
interleukin-6 (Abcam). After 5 days in culture, with media 
changes every 2 days, cell proliferation was measured with 
CellTiter 96 AQueous One Solution Cell Proliferation Assay 
(Promega) at 490 nm (BioTek ELx800 microplate reader, 
Winooski, VT). Final results were normalized to a 
proliferation reading of cells grown in hydrogels for 24 hours 
in normal cell culture medium. 
 
Immunofluorescence and senescence stains 
After 7 days, cells were fixed, permeabilized, and stained. 
The following antibodies were used for 
immunofluorescence: Ki67 (ab16667, 1:200, Abcam), p21 
(ab7903, 1:200, Abcam), alpha smooth muscle actin 
(ab7817, 1:200, Abcam). Beta-galactosidase activity was 
determined using the Senescence Cell Histochemical 
Staining Kit (Sigma-Aldrich) according to the manufacturer’s 
instructions.  Cell nuclei were stained with DAPI at a 
1:10,000 dilution. Samples were imaged on a Zeiss Cell 
Observer SD (Carl Zeiss). 
 
Statistical Analysis 
Statistical analysis was accomplished using GraphPad’s 
Prism v7.0a. Data is reported as the mean ± standard error. 
Unless otherwise noted, a two-tailed t-test was used. P-
values <0.05 are considered significant, where p<0.05 is 
denoted with *, ≤0.01 with **, ≤0.001 with ***, and ≤0.0001 
with ****. 
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